These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23874450)

  • 1. Association of hepatic lipase -514T allele with coronary artery disease and ankle-brachial index, dependence on the lipoprotein phenotype: the GENES study.
    Verdier C; Ruidavets JB; Bongard V; Taraszkiewicz D; Martinez LO; Elbaz M; Ferrières J; Perret B
    PLoS One; 2013; 8(7):e67805. PubMed ID: 23874450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic study of common variants at the Apo E, Apo AI, Apo CIII, Apo B, lipoprotein lipase (LPL) and hepatic lipase (LIPC) genes and coronary artery disease (CAD): variation in LIPC gene associates with clinical outcomes in patients with established CAD.
    Baroni MG; Berni A; Romeo S; Arca M; Tesorio T; Sorropago G; Di Mario U; Galton DJ
    BMC Med Genet; 2003 Sep; 4():8. PubMed ID: 12964943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined hepatic lipase -514C/T and cholesteryl ester transfer protein I405V polymorphisms are associated with the risk of coronary artery disease.
    Ghatrehsamani K; Darabi M; Rahbani M; Hashemzadeh Chaleshtory M; Farrokhi E; Noori M
    Genet Test Mol Biomarkers; 2009 Dec; 13(6):809-15. PubMed ID: 19810818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of 584C/T polymorphism in endothelial lipase gene with risk of coronary artery disease.
    Elnaggar IZ; Hussein S; Amin MI; Abdelaziz EA
    J Cell Biochem; 2019 Sep; 120(9):14414-14420. PubMed ID: 31020688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants.
    van Acker BA; Botma GJ; Zwinderman AH; Kuivenhoven JA; Dallinga-Thie GM; Sijbrands EJ; Boer JM; Seidell JC; Jukema JW; Kastelein JJ; Jansen H; Verhoeven AJ;
    Atherosclerosis; 2008 Sep; 200(1):161-7. PubMed ID: 18164013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic lipase (LIPC) C-514T gene polymorphism is associated with cardiometabolic parameters and cardiovascular risk factors but not with fatty liver in Mexican population.
    Posadas-Sánchez R; Ocampo-Arcos WA; López-Uribe ÁR; Posadas-Romero C; Villarreal-Molina T; León EÁ; Pérez-Hernández N; Rodríguez-Pérez JM; Cardoso-Saldaña G; Medina-Urrutia A; Vargas-Alarcón G
    Exp Mol Pathol; 2015 Feb; 98(1):93-8. PubMed ID: 25550127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol.
    Zambon A; Deeb SS; Hokanson JE; Brown BG; Brunzell JD
    Arterioscler Thromb Vasc Biol; 1998 Nov; 18(11):1723-9. PubMed ID: 9812910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic lipase C514T polymorphism and its relationship with plasma HDL-C levels and coronary artery disease in Koreans.
    Park KW; Choi JH; Chae IH; Cho HJ; Oh S; Kim HS; Lee MM; Park YB; Choi YS
    J Biochem Mol Biol; 2003 Mar; 36(2):237-42. PubMed ID: 12689525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations.
    Shohet RV; Vega GL; Anwar A; Cigarroa JE; Grundy SM; Cohen JC
    Arterioscler Thromb Vasc Biol; 1999 Aug; 19(8):1975-8. PubMed ID: 10446080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial Lipase Gene Polymorphism (584 C/T) in Coronary Artery Patients Among a Turkish Population.
    Solim LA; Gencan IA; Çelik B; Ataacar A; Koç U; Büyükören B; Güngör G; Isbir S
    In Vivo; 2018; 32(5):1105-1109. PubMed ID: 30150432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between a novel polymorphism of hepatic lipase gene and coronary artery disease.
    Su ZG; Zhang SZ; Hou YP; Zhang L; Huang DJ; Liao LC; Xiao CY
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2002 Nov; 34(6):780-5. PubMed ID: 12417924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of associations between CUBN, HNF1A, and LIPC gene polymorphisms and coronary artery disease.
    Park HS; Kim IJ; Kim EG; Ryu CS; Lee JY; Ko EJ; Park HW; Sung JH; Kim NK
    Sci Rep; 2020 Oct; 10(1):16294. PubMed ID: 33004870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
    Kimura H; Miyazaki R; Imura T; Masunaga S; Shimada A; Mikami D; Kasuno K; Takahashi N; Hirano T; Yoshida H
    Nephrology (Carlton); 2011 Aug; 16(6):558-66. PubMed ID: 21352420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study.
    Couture P; Otvos JD; Cupples LA; Lahoz C; Wilson PW; Schaefer EJ; Ordovas JM
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):815-22. PubMed ID: 10712408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic lipase promoter C-480T polymorphism is associated with serum lipids levels, but not subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study.
    Fan YM; Raitakari OT; Kähönen M; Hutri-Kähönen N; Juonala M; Marniemi J; Viikari J; Lehtimäki T
    Clin Genet; 2009 Jul; 76(1):46-53. PubMed ID: 19558527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein subclass and particle size differences in Afro-Caribbeans, African Americans, and white Americans: associations with hepatic lipase gene variation.
    Miljkovic-Gacic I; Bunker CH; Ferrell RE; Kammerer CM; Evans RW; Patrick AL; Kuller LH
    Metabolism; 2006 Jan; 55(1):96-102. PubMed ID: 16324926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rs2070895 (-250G/A) Single Nucleotide Polymorphism in Hepatic Lipase (HL) Gene and the Risk of Coronary Artery Disease in North Indian Population: A Case-Control Study.
    Verma P; Verma DK; Sethi R; Singh S; Krishna A
    J Clin Diagn Res; 2016 Aug; 10(8):GC01-6. PubMed ID: 27656463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variations of the hepatic lipase gene in Korean patients with coronary artery disease.
    Hong SH; Song J; Kim JQ
    Clin Biochem; 2000 Jun; 33(4):291-6. PubMed ID: 10936588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein Lipase (LPL) Polymorphism and the Risk of Coronary Artery Disease: A Meta-Analysis.
    Xie L; Li YM
    Int J Environ Res Public Health; 2017 Jan; 14(1):. PubMed ID: 28275220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.